Trial intelligence / Profile preview

Magnesium in TAP Block for Hysterectomy Pain

NCT02680626Phase 4Terminated

Start
Jan 2016
Primary completion
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of magnesium sulfate in postoperative pain (2 arms). Primary endpoints: Time to first dose of post-operative opioid at 24 hours and Cumulative opioid consumption at 25 hours. Started Jan 2016; status: terminated.

02

Drugs

magnesium sulfate
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02680626.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02680626.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call